Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 171,174 | 170,412 | 216,500 | 187,924 | 183,017 |
| Marketable Securities | 123,212 | 114,835 | 62,144 | 46,262 | 56,301 |
| Receivables | 157,453 | 160,727 | 148,873 | 134,585 | 145,394 |
| Inventories | 170,194 | 176,890 | 185,932 | 191,731 | 185,476 |
| TOTAL | $633,683 | $636,016 | $639,470 | $580,830 | $587,961 |
| Non-Current Assets | |||||
| PPE Net | 307,231 | 310,567 | 308,689 | 310,239 | 307,602 |
| Investments And Advances | 0 | 0 | 0 | 2,047 | 5,913 |
| Other Non-Current Assets | 707,248 | 682,716 | 718,063 | 722,217 | 724,800 |
| TOTAL | $1,014,479 | $993,283 | $1,026,752 | $1,034,503 | $1,038,315 |
| Total Assets | $1,648,162 | $1,629,299 | $1,666,222 | $1,615,333 | $1,626,276 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,671 | 1,641 | 923 | 927 | 224 |
| Accounts payable and accrued liabilities | 152,688 | 148,348 | 190,844 | 166,552 | 175,940 |
| TOTAL | $164,478 | $158,156 | $205,227 | $176,407 | $199,052 |
| Non-Current Liabilities | |||||
| Long Term Debt | 609,801 | 608,749 | 608,582 | 607,727 | 603,858 |
| Other Non-Current Liabilities | 100,492 | 73,589 | 75,667 | 73,717 | 72,083 |
| TOTAL | $710,293 | $682,338 | $684,249 | $681,444 | $675,941 |
| Total Liabilities | $874,771 | $840,494 | $889,476 | $857,851 | $874,993 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,093 | 45,370 | 45,952 | 46,495 | 47,139 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | 673,301 | 666,881 | 642,451 | 625,102 | 594,071 |
| Other shareholders' equity | -5,732 | -5,462 | -4,926 | -5,207 | -7,902 |
| TOTAL | $773,391 | $788,805 | $776,746 | $757,482 | $751,283 |
| Total Liabilities And Equity | $1,648,162 | $1,629,299 | $1,666,222 | $1,615,333 | $1,626,276 |